Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.42 - $0.72 $1,730 - $2,967
-4,121 Reduced 3.86%
102,560 $64,000
Q3 2023

Nov 15, 2023

SELL
$0.6 - $1.53 $240 - $613
-401 Reduced 0.37%
106,681 $64,000
Q2 2023

Aug 11, 2023

BUY
$1.05 - $1.63 $12,124 - $18,821
11,547 Added 12.09%
107,082 $121,000
Q4 2022

Aug 11, 2023

BUY
$1.71 - $3.61 $8,007 - $16,905
4,683 Added 5.15%
95,535 $177,000
Q4 2022

Feb 13, 2023

BUY
$1.71 - $3.61 $8,007 - $16,905
4,683 Added 5.15%
95,535 $177,000
Q3 2022

Aug 11, 2023

SELL
$1.9 - $8.63 $6,081 - $27,624
-3,201 Reduced 3.4%
90,852 $223,000
Q3 2022

Nov 03, 2022

SELL
$1.9 - $8.63 $6,081 - $27,624
-3,201 Reduced 3.4%
90,852 $223,000
Q2 2022

Aug 11, 2023

BUY
$2.13 - $9.01 $23,070 - $97,587
10,831 Added 13.01%
94,053 $229,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $23,070 - $97,587
10,831 Added 13.01%
94,053 $229,000
Q1 2022

Aug 11, 2023

SELL
$6.28 - $15.59 $77,325 - $191,959
-12,313 Reduced 12.89%
83,222 $663,000
Q1 2022

May 20, 2022

SELL
$6.28 - $15.59 $116,939 - $290,301
-18,621 Reduced 18.28%
83,222 $663,000
Q4 2021

Feb 16, 2022

BUY
$14.7 - $28.67 $5,174 - $10,091
352 Added 0.35%
101,843 $1.56 Million
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $230,069 - $317,990
-9,464 Reduced 8.53%
101,491 $2.89 Million
Q2 2021

Aug 12, 2021

BUY
$26.09 - $40.4 $1.12 Million - $1.73 Million
42,743 Added 62.66%
110,955 $3.74 Million
Q1 2021

May 03, 2021

SELL
$33.06 - $56.93 $28,729 - $49,472
-869 Reduced 1.26%
68,212 $2.61 Million
Q4 2020

Feb 12, 2021

BUY
$39.09 - $57.4 $115,002 - $168,870
2,942 Added 4.45%
69,081 $2.89 Million
Q3 2020

Nov 09, 2020

SELL
$28.43 - $44.67 $59,816 - $93,985
-2,104 Reduced 3.08%
66,139 $2.87 Million
Q2 2020

Aug 10, 2020

BUY
$11.71 - $30.29 $148,213 - $383,380
12,657 Added 22.77%
68,243 $1.92 Million
Q1 2020

May 15, 2020

BUY
$7.64 - $27.5 $26,633 - $95,865
3,486 Added 6.69%
55,586 $760,000
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $23,040 - $31,554
-1,534 Reduced 2.86%
52,100 $840,000
Q3 2019

Nov 12, 2019

BUY
$18.85 - $27.5 $12,214 - $17,820
648 Added 1.22%
53,634 $1.01 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $124,733 - $188,644
7,181 Added 15.68%
52,986 $1.25 Million
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $59,916 - $144,869
5,626 Added 14.0%
45,805 $1.07 Million
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $25,029 - $44,275
-2,703 Reduced 6.3%
40,179 $444,000
Q3 2018

Nov 14, 2018

SELL
$7.54 - $18.31 $49,711 - $120,717
-6,593 Reduced 13.33%
42,882 $717,000
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $72,626 - $125,567
14,913 Added 43.15%
49,475 $364,000
Q1 2018

May 15, 2018

SELL
$4.69 - $10.05 $2,917 - $6,251
-622 Reduced 1.77%
34,562 $162,000
Q4 2017

Feb 08, 2018

BUY
$7.86 - $9.99 $20,766 - $26,393
2,642 Added 8.12%
35,184 $320,000
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $289,298 - $338,436
32,542
32,542 $305,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.